mycophenolate mofetil
Drug Details
- Generic Name
- mycophenolate mofetil
- Brand Names
- Mycophenolate Mofetil, mycophenolate mofetil, MYCOPHENOLATE MOFETIL
- Application Number
- ANDA065520
- Sponsor
- Mylan Pharmaceuticals Inc.
- NDC Codes
- 19
- Dosage Forms
- CAPSULE, POWDER, TABLET, TABLET, FILM COATED, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER, FOR SUSPENSION
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- MYCOPHENOLATE MOFETIL
Indications and Usage
1 INDICATIONS AND USAGE Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1)] , heart [see Clinical Studies (14.2)] or liver transplants [see Clinical Studies (14.3)] , in combination with other immunosuppressants. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. (1)